JP5833541B2 - モメタゾンとプロピレングリコールとの水中油型エマルジョン - Google Patents

モメタゾンとプロピレングリコールとの水中油型エマルジョン Download PDF

Info

Publication number
JP5833541B2
JP5833541B2 JP2012510162A JP2012510162A JP5833541B2 JP 5833541 B2 JP5833541 B2 JP 5833541B2 JP 2012510162 A JP2012510162 A JP 2012510162A JP 2012510162 A JP2012510162 A JP 2012510162A JP 5833541 B2 JP5833541 B2 JP 5833541B2
Authority
JP
Japan
Prior art keywords
oil
mometasone
water emulsion
water
propylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012510162A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012526738A5 (enExample
JP2012526738A (ja
Inventor
ハンソン，ヘンリ
カリン モレン，アナ
カリン モレン，アナ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galenica AB
Original Assignee
Galenica AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenica AB filed Critical Galenica AB
Publication of JP2012526738A publication Critical patent/JP2012526738A/ja
Publication of JP2012526738A5 publication Critical patent/JP2012526738A5/ja
Application granted granted Critical
Publication of JP5833541B2 publication Critical patent/JP5833541B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
JP2012510162A 2009-05-12 2010-05-12 モメタゾンとプロピレングリコールとの水中油型エマルジョン Active JP5833541B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200900601 2009-05-12
DKPA200900601 2009-05-12
PCT/EP2010/002921 WO2010130428A1 (en) 2009-05-12 2010-05-12 Oil-in-water emulsion of mometasone and propylene glycol

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015142118A Division JP2015227354A (ja) 2009-05-12 2015-07-16 モメタゾンとプロピレングリコールとの水中油型エマルジョン

Publications (3)

Publication Number Publication Date
JP2012526738A JP2012526738A (ja) 2012-11-01
JP2012526738A5 JP2012526738A5 (enExample) 2013-06-27
JP5833541B2 true JP5833541B2 (ja) 2015-12-16

Family

ID=42352732

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012510162A Active JP5833541B2 (ja) 2009-05-12 2010-05-12 モメタゾンとプロピレングリコールとの水中油型エマルジョン
JP2015142118A Pending JP2015227354A (ja) 2009-05-12 2015-07-16 モメタゾンとプロピレングリコールとの水中油型エマルジョン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015142118A Pending JP2015227354A (ja) 2009-05-12 2015-07-16 モメタゾンとプロピレングリコールとの水中油型エマルジョン

Country Status (20)

Country Link
US (2) US8728497B2 (enExample)
EP (2) EP2962688B1 (enExample)
JP (2) JP5833541B2 (enExample)
CN (1) CN102458382B (enExample)
AU (1) AU2010246613B2 (enExample)
BR (1) BRPI1010907B8 (enExample)
CA (1) CA2761739C (enExample)
CY (1) CY1116667T1 (enExample)
DK (1) DK2429510T3 (enExample)
ES (2) ES2813400T3 (enExample)
HR (1) HRP20150959T1 (enExample)
HU (1) HUE027718T2 (enExample)
MX (1) MX345888B (enExample)
NZ (1) NZ596429A (enExample)
PL (2) PL2962688T3 (enExample)
PT (1) PT2429510E (enExample)
RU (1) RU2526911C2 (enExample)
SI (1) SI2429510T1 (enExample)
SM (1) SMT201500297B (enExample)
WO (1) WO2010130428A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1010907B8 (pt) 2009-05-12 2021-05-25 Galenica Ab emulsão de óleo-em-água de mometasona e propileno-glicol
PT105982B (pt) * 2011-11-03 2014-07-29 Laboratório Edol Produtos Farmac Uticos S A Composição e método de preparação a frio de uma emulsão utilizada como veículo de fármacos anti-inflamatórios
JP7262227B2 (ja) * 2017-10-23 2023-04-21 マルホ株式会社 被膜形成外用剤
US20190282465A1 (en) * 2018-03-19 2019-09-19 Essential Lipid Technologies, LLC Topical Phospholipid Formulations and Methods for Preparing the Same
CN120500342A (zh) 2022-12-20 2025-08-15 格林尼卡皮肤股份公司 用于局部皮肤治疗的新的组合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282216A (en) * 1977-04-20 1981-08-04 Johnson & Johnson Topical anti-inflammatory drug therapy
US4808610A (en) 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US5422361A (en) * 1989-12-20 1995-06-06 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
US6127353A (en) 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
WO1994013257A1 (en) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
US5696105A (en) * 1996-03-14 1997-12-09 Hackler; Walter A. Antifungal nail composition
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
US6075056A (en) 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
US6720001B2 (en) * 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US7030203B2 (en) * 2001-09-28 2006-04-18 3M Innovative Properties Company Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
AR038628A1 (es) * 2002-03-04 2005-01-19 Novartis Ag Composicion oftalmica
TR200201343A2 (tr) 2002-05-17 2003-12-22 Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. Kortikosteroid ve antiseptik içeren farmasötik bileşim
MXPA05002248A (es) 2002-08-27 2005-06-08 Schering Corp Procedimiento para producir formulaciones de inhalador de dosis medida.
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20060104968A1 (en) * 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
WO2004105686A2 (en) 2003-05-23 2004-12-09 Taro Pharmaceuticals U.S.A., Inc. Novel topical steroid cream formulations
EP1631290A2 (en) 2003-05-23 2006-03-08 Combinatorx, Incorporated Combination therapy for the treatment of neoplasms
US20050196462A1 (en) * 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
DE102006034883A1 (de) 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
EP2120868A4 (en) 2007-04-11 2010-08-25 Perrigo Israel Phamaceuticals LOW-DOSED MOMETASON FORMULATIONS
DK2429490T3 (en) 2009-05-12 2017-02-20 Galenica Ab OIL-IN-WATER EMULSION OF MOMETASON
BRPI1010907B8 (pt) 2009-05-12 2021-05-25 Galenica Ab emulsão de óleo-em-água de mometasona e propileno-glicol

Also Published As

Publication number Publication date
JP2015227354A (ja) 2015-12-17
PT2429510E (pt) 2015-10-12
US20120171252A1 (en) 2012-07-05
US20140242171A1 (en) 2014-08-28
AU2010246613B2 (en) 2014-07-17
ES2547556T3 (es) 2015-10-07
CN102458382B (zh) 2015-03-18
HUE027718T2 (en) 2016-10-28
SMT201500297B (it) 2016-01-08
CN102458382A (zh) 2012-05-16
RU2011150246A (ru) 2013-06-20
CA2761739C (en) 2017-03-07
EP2962688A1 (en) 2016-01-06
NZ596429A (en) 2013-08-30
MX345888B (es) 2017-02-22
EP2429510B1 (en) 2015-06-24
CY1116667T1 (el) 2017-03-15
JP2012526738A (ja) 2012-11-01
WO2010130428A1 (en) 2010-11-18
US11395827B2 (en) 2022-07-26
DK2429510T3 (en) 2015-09-28
AU2010246613A1 (en) 2011-12-08
EP2962688B1 (en) 2020-06-24
PL2962688T3 (pl) 2020-11-02
US8728497B2 (en) 2014-05-20
MX2011011959A (es) 2012-05-08
BRPI1010907B1 (pt) 2020-10-20
HRP20150959T1 (hr) 2015-11-06
CA2761739A1 (en) 2010-11-18
EP2429510A1 (en) 2012-03-21
SI2429510T1 (sl) 2015-10-30
RU2526911C2 (ru) 2014-08-27
BRPI1010907A2 (pt) 2016-03-15
ES2813400T3 (es) 2021-03-23
PL2429510T3 (pl) 2015-12-31
BRPI1010907B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
US9730866B2 (en) Emulsion composition
TW200920410A (en) Liquid cosmetic preparation
JPS63150221A (ja) 結晶性薬物含有乳化組成物
JP2015227354A (ja) モメタゾンとプロピレングリコールとの水中油型エマルジョン
JP2022501314A (ja) 局所用組成物
JP7094321B2 (ja) 少なくとも１種のセラミド、少なくとも１種のスフィンゴイド塩基及びクエン酸トリエチルを含有する組成物
US20230123488A1 (en) Stable topical tetracycline compositions
JP2822093B2 (ja) Ｗ／ｏ／ｗ型乳化化粧料
US20220331238A1 (en) Oil-in-water emulsion of mometasone
PL183588B1 (pl) Środek przeciwzapalny do użytku zewnętrznego zawierający nimesulid
US12447161B2 (en) Topical pharmaceutical formulation
JP6084579B2 (ja) タクロリムスを含有する水中油型クリーム状組成物
US20240091138A1 (en) Topical composition comprising pregabalin
CA2156396A1 (en) Stable dermatologic preparation containing mycophenolic acid
JP2003073276A (ja) 安定化された抗炎症軟膏剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130508

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130508

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140617

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140917

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150317

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150716

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150901

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151006

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151029

R150 Certificate of patent or registration of utility model

Ref document number: 5833541

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250